IMAGE

Figure 2

ID
ZDB-IMAGE-211201-46
Source
Figures for Dong et al., 2021
Image
Figure Caption

Figure 2

BTDE reduces HUVECs tube formation and MMP9 activity. (a) HUVECs was pretreated with BTDE for 24 h, then seeded on matrigel for 20 h, capillary-like structures of HUVECs were recorded by inverted microscope (original magnification, 4×; scale bar: 600 μm) and total length of tubes was measured by Image J software. (b) Different concentrations of BTDE were added after tubes have established on matrigel for 8 h, and incubated for another 6 h. Tubular structures were observed by inverted microscope (original magnification, 4×; scale bar: 600 μm) and total length of tubes compared with 0 μM was measured by Image J software. (c) Gelatin zymography experiment was used to detect the MMP9 activity of HUVECs after 24 h treatment of BTDE, GAPDH was used as an internal control. (d) Western blot was used to measure the VEGF, HIF-1α, β-catenin, AKT, and ERK as well as their phosphorylation levels in HUVECs treated with BTDE for 24 h. Data represent mean ± SD of three independent experiments. * p < 0.05, ** p < 0.01 versus control.

Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Mar. Drugs